83 related articles for article (PubMed ID: 38438872)
1. Baicalein increases cisplatin sensitivity of A549 lung adenocarcinoma cells via PI3K/Akt/NF-κB pathway.
Yu M; Qi B; Xiaoxiang W; Xu J; Liu X
Biomed Pharmacother; 2017 Jun; 90():677-685. PubMed ID: 28415048
[TBL] [Abstract][Full Text] [Related]
2. Regulation of Inflammatory Functions of Macrophages and T Lymphocytes by NFAT5.
Aramburu J; López-Rodríguez C
Front Immunol; 2019; 10():535. PubMed ID: 30949179
[TBL] [Abstract][Full Text] [Related]
3. TonEBP/NFAT5 expression is associated with cisplatin resistance and migration in macrophage-induced A549 cells.
Song HJ; Kim YH; Choi HN; Kim T; Kim SJ; Kang MW; Lee SD
BMC Mol Cell Biol; 2024 Mar; 25(1):6. PubMed ID: 38438872
[TBL] [Abstract][Full Text] [Related]
4. TonEBP expression is essential in the IL-1β-induced migration and invasion of human A549 lung cancer cells.
Song HJ; Kim T; Choi HN; Kim SJ; Lee SD
Oncol Res; 2023; 32(1):151-161. PubMed ID: 38188678
[TBL] [Abstract][Full Text] [Related]
5. Osmoprotective transcription factor NFAT5/TonEBP modulates nuclear factor-kappaB activity.
Roth I; Leroy V; Kwon HM; Martin PY; Féraille E; Hasler U
Mol Biol Cell; 2010 Oct; 21(19):3459-74. PubMed ID: 20685965
[TBL] [Abstract][Full Text] [Related]
6. The role of emodin on cisplatin resistance reversal of lung adenocarcinoma A549/DDP cell.
Teng X; Wang SY; Shi YQ; Fan XF; Liu S; Xing Y; Guo YY; Dong M
Anticancer Drugs; 2021 Oct; 32(9):939-949. PubMed ID: 34001704
[TBL] [Abstract][Full Text] [Related]
7. Tonicity-responsive enhancer-binding protein promotes stemness of liver cancer and cisplatin resistance.
Lee JH; Suh JH; Kang HJ; Choi SY; Jung SW; Lee-Kwon W; Park SA; Kim H; Ye BJ; Yoo EJ; Jeong GW; Park NH; Kwon HM
EBioMedicine; 2020 Aug; 58():102926. PubMed ID: 32739873
[TBL] [Abstract][Full Text] [Related]
8. MiR-192/NKRF axis confers lung cancer cell chemoresistance to cisplatin via the NF-κB pathway.
Li Y; Zu L; Wu H; Zhang F; Fan Y; Pan H; Du X; Guo F; Zhou Q
Thorac Cancer; 2022 Feb; 13(3):430-441. PubMed ID: 34953057
[TBL] [Abstract][Full Text] [Related]
9. The evolving role of TonEBP as an immunometabolic stress protein.
Choi SY; Lee-Kwon W; Kwon HM
Nat Rev Nephrol; 2020 Jun; 16(6):352-364. PubMed ID: 32157251
[TBL] [Abstract][Full Text] [Related]
10. Tumor Microenvironment.
Arneth B
Medicina (Kaunas); 2019 Dec; 56(1):. PubMed ID: 31906017
[TBL] [Abstract][Full Text] [Related]
11. Inflammation and cancer.
Singh N; Baby D; Rajguru JP; Patil PB; Thakkannavar SS; Pujari VB
Ann Afr Med; 2019; 18(3):121-126. PubMed ID: 31417011
[TBL] [Abstract][Full Text] [Related]
12. The Tumor Microenvironment Innately Modulates Cancer Progression.
Hinshaw DC; Shevde LA
Cancer Res; 2019 Sep; 79(18):4557-4566. PubMed ID: 31350295
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of nuclear factor of activated T-cells 5 expression in non-small cell lung cancer patients who underwent surgical resection.
Cho HJ; Yun HJ; Yang HC; Kim SJ; Kang SK; Che C; Lee SD; Kang MW
J Surg Res; 2018 Jun; 226():40-47. PubMed ID: 29661287
[TBL] [Abstract][Full Text] [Related]
14. NFAT5-Regulated Macrophage Polarization Supports the Proinflammatory Function of Macrophages and T Lymphocytes.
Tellechea M; Buxadé M; Tejedor S; Aramburu J; López-Rodríguez C
J Immunol; 2018 Jan; 200(1):305-315. PubMed ID: 29150563
[TBL] [Abstract][Full Text] [Related]
15. Suppression of NFAT5-mediated Inflammation and Chronic Arthritis by Novel κB-binding Inhibitors.
Han EJ; Kim HY; Lee N; Kim NH; Yoo SA; Kwon HM; Jue DM; Park YJ; Cho CS; De TQ; Jeong DY; Lim HJ; Park WK; Lee GH; Cho H; Kim WU
EBioMedicine; 2017 Apr; 18():261-273. PubMed ID: 28396011
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
